Magnetar Financial’s Novartis NVS Stock Holding History

Magnetar Financial’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,305,446	Closed	-$139M	–	634
2024 Q2	$139M	Sell	1,305,446 -600,600	-32%	-$60.3M	2.9%	2
2024 Q1	$184M	Buy	1,906,046 +666,104	+54%	+$68.3M	4.13%	1
2023 Q4	$125M	Buy	1,239,942 +440,244	+55%	+$42.5M	3.18%	3
2023 Q3	$81.5M	Buy	799,698 +469,986	+143%	+$47.7M	2.08%	11
2023 Q2	$33.3M	Buy	+329,712	New	+$33M	0.73%	48
2021 Q1	–	Sell	-161,379	Closed	-$15.2M	–	1156
2020 Q4	$15.2M	Sell	161,379 -61,777	-28%	-$5.4M	0.22%	98
2020 Q3	$19.4M	Buy	223,156 +152,036	+214%	+$13.2M	0.34%	74
2020 Q2	$6.21M	Buy	+71,120	New	+$6.14M	0.18%	105
2020 Q1	–	Sell	-210,182	Closed	-$19.9M	–	584
2019 Q4	$19.9M	Buy	210,182 +156,182	+289%	+$14M	0.42%	53
2019 Q3	$4.69M	Buy	54,000 +4,000	+8%	+$359K	0.12%	109
2019 Q2	$4.57M	Sell	50,000 -220	-0.4%	-$18.6K	0.09%	97
2019 Q1	$4.33M	Buy	+50,220	New	+$4.03M	0.11%	82

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Magnetar Financial's NVS Position: Q3 2024 in Review

Magnetar Financial sold out of Novartis (NVS) in Q3 2024, closing a stake of 1,305,446 shares — an estimated $139M sold.

Magnetar Financial first reported a position in NVS in Q1 2019 and held it in 12 quarters. The position peaked at $184M in Q1 2024. 1,311 funds tracked by Wall St. Rank hold NVS as of Q3 2024.

Magnetar Financial reported no remaining Novartis position as of Q3 2024 after selling out during the quarter.
Magnetar Financial sold 1,305,446 Novartis shares in Q3 2024, an estimated $139M.
Magnetar Financial first reported a position in Novartis in Q1 2019 and held it in 12 quarters.
Magnetar Financial's Novartis position peaked at $184M in Q1 2024.
1,311 funds tracked by Wall St. Rank held Novartis as of Q3 2024.

Based on Magnetar Financial's 13F filing for Q3 2024, filed 13 Nov 2024.